Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Telix Pharmaceuticals Limited TLX

Full chart Compare
Set alert

Price alert · TLX

All alert types
9.03 USD -0.02 (-0.22%)

At closeNov 3, 2026, 4:01 PM EST

9.03 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

9.01 Day range 9.09
6.28 52-week range 13.11
YTD
+20.56%
1 year
-13.09%

Financial health

Altman Z-Score

3.76 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -362×
FY 2016: -70008×FY 2017: -390×FY 2018: -314×FY 2019: -180×FY 2020: -116×FY 2021: -71.9×FY 2022: -67.3×FY 2023: 1364×FY 2024: 166×FY 2025: -362×
FY 2016 5y median -67.3× FY 2025
P/S 3.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 22251×FY 2019: 1446×FY 2020: 972×FY 2021: 774×FY 2022: 43.1×FY 2023: 14.1×FY 2024: 10.5×FY 2025: 3.2×
FY 2016 5y median 14.1× FY 2025
P/B 6.1×
FY 2016: 0.0×FY 2017: 50.4×FY 2018: 82.1×FY 2019: 71.9×FY 2020: 64.1×FY 2021: 2726×FY 2022: 86.3×FY 2023: 47.7×FY 2024: 14.5×FY 2025: 6.1×
FY 2016 5y median 47.7× FY 2025
P/FCF -46.7×
FY 2016: 0.0×FY 2017: -411×FY 2018: -209×FY 2019: -212×FY 2020: 2959×FY 2021: -96.9×FY 2022: -97.2×FY 2023: 500×FY 2024: 287×FY 2025: -46.7×
FY 2016 5y median -46.7× FY 2025
EV/EBITDA 54.6×
FY 2016: 0.0×FY 2017: -429×FY 2018: -147×FY 2019: -204×FY 2020: -127×FY 2021: -83.7×FY 2022: -73.2×FY 2023: 304×FY 2024: 80.6×FY 2025: 54.6×
FY 2016 5y median 54.6× FY 2025
EV/Sales 3.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 22128×FY 2019: 1433×FY 2020: 957×FY 2021: 772×FY 2022: 42.5×FY 2023: 13.9×FY 2024: 10.4×FY 2025: 3.6×
FY 2016 5y median 13.9× FY 2025
FCF Yield -2.1%
FY 2016: 0.0%FY 2017: -0.2%FY 2018: -0.5%FY 2019: -0.5%FY 2020: 0.0%FY 2021: -1.0%FY 2022: -1.0%FY 2023: 0.2%FY 2024: 0.3%FY 2025: -2.1%
FY 2016 5y median -1.0% FY 2025

Profitability

Gross Margin 53.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 27.0%FY 2020: 61.2%FY 2021: 66.5%FY 2022: 59.3%FY 2023: 62.6%FY 2024: 65.1%FY 2025: 53.1%
FY 2016 5y median 62.6% FY 2025
Operating Margin 2.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -14167.6%FY 2019: -1145.8%FY 2020: -847.7%FY 2021: -1069.6%FY 2022: -57.4%FY 2023: 3.2%FY 2024: 10.5%FY 2025: 2.2%
FY 2016 5y median 2.2% FY 2025
Net Margin -0.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -7087.1%FY 2019: -799.6%FY 2020: -861.1%FY 2021: -1059.9%FY 2022: -65.0%FY 2023: 1.0%FY 2024: 6.4%FY 2025: -0.9%
FY 2016 5y median -0.9% FY 2025
ROE -1.7%
FY 2016: 0.0%FY 2017: -12.9%FY 2018: -26.1%FY 2019: -39.8%FY 2020: -56.8%FY 2021: -3730.8%FY 2022: -130.1%FY 2023: 3.5%FY 2024: 8.8%FY 2025: -1.7%
FY 2016 5y median -1.7% FY 2025
ROIC 1.8%
FY 2016: 0.0%FY 2017: -11.4%FY 2018: -35.0%FY 2019: -38.7%FY 2020: -29.8%FY 2021: -91.1%FY 2022: -53.7%FY 2023: 6.5%FY 2024: 6.1%FY 2025: 1.8%
FY 2016 5y median 1.8% FY 2025
ROA -0.6%
FY 2016: 0.0%FY 2017: -12.5%FY 2018: -18.0%FY 2019: -27.2%FY 2020: -28.4%FY 2021: -73.3%FY 2022: -40.8%FY 2023: 1.3%FY 2024: 3.3%FY 2025: -0.6%
FY 2016 5y median -0.6% FY 2025

Growth (YoY)

Revenue 0.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 1685.9%FY 2020: 49.6%FY 2021: 45.7%FY 2022: 2007.6%FY 2023: 213.9%FY 2024: 55.8%FY 2025: 0.8%
FY 2016 FY 2025
Operating Income -78.7%
FY 2016: 74.1%FY 2017: -18933.6%FY 2018: -384.2%FY 2019: -44.4%FY 2020: -10.7%FY 2021: -83.9%FY 2022: -13.1%FY 2023: 117.2%FY 2024: 418.5%FY 2025: -78.7%
FY 2016 FY 2025
EPS (diluted) -114.8%
FY 2016: 81.3%FY 2017: -16500.0%FY 2018: -37.3%FY 2019: -75.4%FY 2020: -41.7%FY 2021: -70.6%FY 2022: -13.8%FY 2023: 104.9%FY 2024: 769.6%FY 2025: -114.8%
FY 2016 FY 2025
Free Cash Flow -289.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -243.7%FY 2019: -14.4%FY 2020: 107.2%FY 2021: -3643.6%FY 2022: -17.0%FY 2023: 120.0%FY 2024: 102.1%FY 2025: -289.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 0.0×FY 2017: 33.7×FY 2018: 4.4×FY 2019: 5.5×FY 2020: 4.7×FY 2021: 1.3×FY 2022: 2.0×FY 2023: 1.4×FY 2024: 2.8×FY 2025: 1.4×
FY 2016 5y median 1.4× FY 2025
Quick Ratio 1.3×
FY 2016: 0.0×FY 2017: 33.7×FY 2018: 4.3×FY 2019: 5.5×FY 2020: 4.7×FY 2021: 1.2×FY 2022: 2.0×FY 2023: 1.3×FY 2024: 2.7×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
Debt / Equity 1.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 1.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 1.0×FY 2025: 1.1×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 6.2×
FY 2016: 0.0×FY 2017: 8.5×FY 2018: 0.8×FY 2019: 1.7×FY 2020: 1.9×FY 2021: 0.3×FY 2022: 1.1×FY 2023: -4.6×FY 2024: -1.3×FY 2025: 6.2×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.5×
FY 2016: 0.0×FY 2017: -607×FY 2018: -953×FY 2019: -16.6×FY 2020: -37.6×FY 2021: -415×FY 2022: -226×FY 2023: 1.8×FY 2024: 3.8×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31